BRII BIOSCIENCES L revenue for the last year amounted to 678.78 k HKD, the most of which — 681.78 k HKD — came from its highest performing source at the moment, Therapies for Infectious Diseases and Central Nervous System Diseases, the year earlier bringing 60.03 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought BRII BIOSCIENCES L 681.78 k HKD, and the year before that — 60.03 M HKD.